Compare Global X CleanTech (CTEC) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X CleanTech vs 22nd Century Group Inc — how do they compare? Global X CleanTech trades at $56.22 (market cap $24.57M), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Global X CleanTech is far larger — about 39.5× 22nd Century Group Inc's market cap, and Global X CleanTech is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X CleanTech for 42 Days and 22nd Century Group Inc for 32 Days on average.
| CTEC | XXII | |
|---|---|---|
Market Cap | $24.57M | $621.67K |
Volume | 1,220 | 45,625 |
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $78.11 | $483.00 |
52-Week Low | $50.82 | $0.80 |
Typical Hold Time | 42 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTEC trades at $56.36, up 0.25% today, with a bullish technical signal from moving averages and strong trend strength (ADX 46.60). The stock faces resistance near $58 and support at $57. Key financial ratios like P/E and P/S are not provided, limiting fundamental clarity.
The outlook hinges on upcoming earnings to validate growth. Risks include opaque financials and market volatility. Analyst sentiment is mixed, with institutional interest needed to confirm the bullish technical setup.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
